Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,952,089
+$2,668,676 QoQ
Shares Held
34,653
+705.9% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#190
of 477 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$5,699,211
PutShares
66,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. CYTK ranks #14 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
134,214 | $40,402,439 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
223,995 | $21,835,032 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,306 | $13,908,683 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
347,106 | $10,850,533 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
5,112,098 | $8,521,240 | |
| 6 | ARGX |
Argenx SE
|
8,200 | $7,607,714 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
150,200 | $7,065,408 | |
| 8 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 |
All Filings in CYTK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,952,089 | 34,653 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $5,699,211 | 66,900 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $6,656,910 | 101,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $164,775 | 2,500 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $283,413 | 4,300 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $803,800 | 20,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,861,395 | 103,346 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,228,120 | 174,775 | Shares | Sole | 2024-11-07 | |
| 2024-03-31 | $350,550 | 5,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $17,758,323 | 212,700 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $16,455,879 | 197,100 | Put | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||